Pheton Holdings Ltd Class A Ordinary Shares PTHL

Full chart Compare

Set alert

0.28 USD 0.00 (+0.00%)

Mar 19, 2026, 9:30 AM EDT

0.2714 Day range 0.30

3.32 52-week range 6.45

YTD: -33.10%
1 year: -91.89%

Market cap: 85.74M
Revenue (ttm): 572.29K
Profit margin: -77.36%
EPS (ttm): -0.03
Shares out: 6.58M
YTD return: -33.10%
1-year return: -91.89%

Volume: 106.32K
Avg volume: 144.53K
Open: 0.2714
Previous close: 0.2815
Day's range: 0.2714 – 0.30
52-week range: 3.32 – 6.45

1D 5D 1M 3M 6M YTD 1Y 2Y 5Y MAX ALL

Customize chart

2Y -4.0085 (-93.44%)

Enterprise value: 50.40M
PEG ratio: 0.00
Price / sales: 149.81
Price / book: 4050.00
Dividend yield: 0.00%
Payout ratio: 0.00%
Revenue growth: -21.10%
Free cash flow: 0
Total cash: 17.85K
Total debt: 377.65K
Return on equity: -188.15%
Short % of float: 0.00%
50-day average: 4.43
200-day average: 4.51

Consensus EPS estimate 0.00.

Earnings history

Financials — quick view

PTHL Revenue — annual 448.20K

PTHL Net income — annual -660.59K

PTHL EPS — annual -0.052

Pheton Holdings Ltd, a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. The company's proprietary treatment planning system is a radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. Its proprietary treatment planning system is FTTPS, a treatment planning system for treating various malignant tumors, which could determine the target volume, prescription dose, and dose limitation to protect organs at risks and produce dose distribution plan for brachytherapy for cancer patients. The company was founded in 1998 and is based in Beijing, China. Pheton Holdings Ltd is a subsidiary of ZJW (BVI) LTD.

Sector: Healthcare
Industry: Medical Devices
Country: China
Website: ftzy.com.cn